Science Explorer Back to mapMap

Most cited papers from St. Gallen Oncology Conferences

What are the most cited papers from St. Gallen Oncology Conferences?

The most cited paper from St. Gallen Oncology Conferences is "Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021" (Harold J. Burstein et al., 2021), with 842 citations. Next come "The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023" (330) and "Clinical multidrug resistance in cancer: A multifactorial problem" (178).

Showing 27 of 27 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 Harold J. Burstein et al. · Annals of Oncology Open access 6 Jul 2021 842
2 The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 Lisa M Force et al. · The Lancet Open access1,377 authors 25 Sep 2025 330
3 Clinical multidrug resistance in cancer: A multifactorial problem Manfred Lehnert · European Journal of Cancer Jun 1996 178
4 The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma Ronan Le Moigne et al. · Molecular Cancer Therapeutics 6 Sep 2017 117
5 Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer Omar Hasan Ali, Stefan Diem, Eva Markert et al. · OncoImmunology Open access 19 Sep 2016 117
6 Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study Sheela Rao, Naureen Starling, David Cunningham et al. · Annals of Oncology Open access 25 May 2010 116
7 Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients Adrian Egli, Isabelle Binet, S. Binggeli et al. · Journal of Translational Medicine Open access 9 Jun 2008 114
8 Cell‐free DNA — Minimally invasive marker of hematological malignancies Veronika Kubaczková, Dávid Vrábel, Lenka Sedlaříková et al. · European Journal Of Haematology Open access 10 Jul 2017 33
9 Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience Cédric Michael Panje, Thierry Panje, Paul Martin Putora et al. · Radiation Oncology Open access 21 Feb 2015 25
10 In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases Alberto Ocaña, Javier Pérez‐Peña, Ana Lucía Alcaraz-Sanabria et al. · Oncotarget Open access 16 Mar 2016 23
11 Sexual Satisfaction and Frequency of Orgasm in Women with Chronic Pelvic Pain due to Endometriosis Silvan Hämmerli, Alexandra Kohl Schwartz, Patrick Imesch et al. · The Journal of Sexual Medicine 5 Oct 2020 21
12 Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts Paul Martin Putora et al. · Radiotherapy and Oncology 15 Mar 2019 16
13 Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action Carole Bandiera, Janette Ribaut, Alexandra Lelia Dima et al. · International Journal of Public Health Open access 12 Aug 2022 15
14 Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus ( HIV )‐protease inhibitors lopinavir or nelfinavir Dominik Abt, Andrej Bešše, Lenka Sedlaříková et al. · British Journal of Urology 21 Nov 2017 15
15 Receptor‐Mediated Targeting of Cathepsins in Professional Antigen Presenting Cells Ulrik Hillaert, Martijn Verdoes, Bogdan I. Florea et al. · Angewandte Chemie 20 Jan 2009 14
16 Nasolacrimal Duct Obstruction Caused by Lymphoproliferative Infiltration in the Course of Chronic Lymphocytic Leukemia Ralph Litschel, Marco Siano, Abel‐Jan Tasman et al. · Allergy & Rhinology Open access 2015 14
17 Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades Manfred Kaufmann, Gϋnter von Minckwitz, Jonas C. S. Bergh et al. · Archives of Gynecology and Obstetrics 4 Nov 2013 13
18 Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects C. Herrmann, Rudolf Morant, Esther Walser et al. · BMC Cancer Open access 6 Mar 2021 11
19 Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study Michael Thomas Mark, Sylvie Rusakiewicz, Martin Früh et al. · ESMO Open Open access 12 Apr 2022 7
20 The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brieftool for clinical decision-making in older cancer patients Kerri M. Clough‐Gorr, Lea Noti, Peter Brauchli et al. · BMC Medical Informatics and Decision Making Open access 23 Aug 2013 7
21 Regional differences and trends in breast cancer surgical procedures and their relation to socioeconomic disparities and screening patterns C. Herrmann, Silvia M. Ess, Esther Walser et al. · Journal of Public Health Open access 6 Jan 2019 4
22 Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study GBD 2023 IHD & Dietary Risk Factors Collaborators et al. · Nature Medicine 1,040 authors 30 Mar 2026 3
23 The importance of evidence-based international consensus in the primary treatment of breast cancer – a periodic ‘must’ Hans-Jörg Senn, Beat J. K. Thurlimann · The Breast Open access 24 Nov 2003 3
24 Follow-up imaging after hospital discharge for acute intracerebral hemorrhage in European academic hospitals: a decision-making analysis Gonçalo G. Almeida et al. · Neuroradiology Open access 4 Mar 2026 0
25 2907P Understanding geriatric oncology in Switzerland: Results of a nationwide assessment M. Vetter, Elena Diana Chiru, Roch‐Philippe Charles et al. · Annals of Oncology Open access Sep 2025 0
26 Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis B. Thürlimann · Archives of Gynecology and Obstetrics Dec 1994 0
27 Excruciating Thigh Pain and Hepatic Air Collection D. Koeberle, Irene Peter, K. Boggian et al. · Clinical Infectious Diseases 5 Dec 2007 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.